Comprehensive heart failure treatment at Livasa Hospital including medical therapy, device therapy and advanced options for reduced and preserved ejection fraction. Call +91-80788 80788.

Content:

Heart failure is a complex clinical syndrome affecting millions globally, characterized by the heart's inability to pump sufficient blood to meet the body's metabolic demands. Modern heart failure management at Livasa Hospital employs evidence-based approaches combining optimal medical therapy, device therapies and advanced treatment options to improve symptoms, reduce hospitalisations and improve survival.

Understanding Heart Failure

Heart failure results from various causes leading to either reduced systolic function (HFrEF) or preserved systolic function (HFpEF):

Heart Failure with Reduced Ejection Fraction (HFrEF):

  • Ejection fraction <40 percent

  • Primarily systolic dysfunction

  • Common causes: CAD, hypertension, cardiomyopathy, valve disease

Heart Failure with Preserved Ejection Fraction (HFpEF):

  • Ejection fraction ≥50 percent

  • Primarily diastolic dysfunction

  • Common in elderly, hypertensive, diabetic patients

Both forms result in similar symptoms but have different pathophysiology and treatment approaches.

Clinical Presentation

Heart failure symptoms vary with severity and acuity:

Pulmonary Congestion Symptoms:

  • Shortness of breath at rest or with exertion

  • Orthopnoea (breathlessness when lying flat)

  • Paroxysmal nocturnal dyspnoea (sudden nighttime breathlessness)

  • Dry or wet cough

Systemic Congestion Symptoms:

  • Peripheral oedema (ankle and leg swelling)

  • Hepatomegaly (enlarged liver) with right upper quadrant discomfort

  • Weight gain (>2–3 kg over days)

  • Abdominal distension

Low Cardiac Output Symptoms:

  • Fatigue and weakness

  • Dizziness or syncope

  • Reduced exercise tolerance

  • Mental confusion (in severe cases)

Comprehensive Diagnostic Evaluation

Heart failure diagnosis and characterisation includes:

Diagnostic Test Specific Information Obtained
Clinical history and exam Symptom characterisation and physical findings
12-lead ECG Rhythm, QRS duration, chamber enlargement
Chest X-ray Pulmonary congestion, cardiomegaly
Transthoracic echo Ejection fraction, chamber dimensions, valve function
BNP or NT-proBNP Biomarker of ventricular stress
Coronary angiography Identify CAD as aetiology
Right heart catheterization Detailed haemodynamic assessment in complex cases
Cardiac MRI Myocardial characterisation, ischaemia detection

Medical Therapy for Heart Failure

HFrEF Medical Management (Cornerstone Therapies):

Medication Class Mechanism and Benefits
ACE inhibitors or ARBs Reduce afterload, prevent remodelling
Beta-blockers Reduce heart rate, blood pressure, prevent arrhythmias
Aldosterone antagonists Additional remodelling prevention, diuretic-sparing
SGLT2 inhibitors Reduce hospitalisation, mortality in HFrEF
Hydralazine/nitrate Vasodilation in special populations
Diuretics Symptom relief in congestive states
Digoxin Inotropic support in selected patients

HFpEF Medical Management:

  • Blood pressure and heart rate control

  • Diuretics for congestion relief

  • Treatment of underlying comorbidities

  • Limited specific therapies; newer agents under investigation

Device Therapies

Implantable Cardioverter Defibrillators (ICDs):

  • For patients at high sudden cardiac death risk

  • Particularly those with QRS duration >120 ms

Cardiac Resynchronisation Therapy (CRT):

  • For patients with wide QRS complex (>120 ms) and significant dysfunction

  • Improves cardiac output through sequential pacing

Advanced Heart Failure Therapies

Inotropic Support:

  • Continuous dobutamine or milrinone infusions for end-stage disease

  • Improves symptoms in hospitalised patients

Mechanical Circulatory Support:

  • Left ventricular assist devices (LVADs) for select patients

  • Bridge to transplantation or destination therapy

Heart Transplantation:

  • Definitive therapy for end-stage disease

  • Limited availability; careful patient selection required

Lifestyle and Risk Factor Management

Critical components of heart failure management:

  • Sodium restriction – Usually <2 grams daily

  • Fluid restriction – Typically 1–1.5 litres daily in advanced disease

  • Weight monitoring – Daily weights to detect fluid accumulation

  • Controlled exercise – Supervised cardiac rehabilitation

  • Sleep quality – Treatment of sleep disorders

  • Medication adherence – Critical for outcomes

  • Smoking cessation – Complete elimination

  • Alcohol limitation – Or complete avoidance

Heart Failure Clinic Model

Livasa Hospital provides integrated heart failure services:

  • Specialist heart failure cardiologists

  • Nursing support and patient education

  • Dietitian counselling

  • Psychosocial support

  • Device clinics and remote monitoring

  • Palliative care integration when appropriate

Expected Outcomes

Modern heart failure management achieves:

  • Reduced symptom burden and improved quality of life

  • Decreased hospitalisations

  • Improved survival (particularly HFrEF)

  • Enhanced exercise capacity

  • Delayed disease progression

Why Choose Livasa Hospital?

  • Specialist heart failure management team

  • Access to all evidence-based medical therapies

  • Device therapy programs (ICD, CRT, LVAD evaluation)

  • Comprehensive monitoring and surveillance

  • Multidisciplinary approach to care

NAP – Contact Details

Livasa Hospital Mohali
Sector 71, Sahibzada Ajit Singh Nagar (SAS Nagar)
Mohali, Punjab – 160071
Phone: +91-80788 80788 (24/7 Emergency)
Website: www.livasahospitals.com

Call +91-80788 80788 to enrol in the heart failure management program at Livasa Hospital.

Request an Appointment

Now Book Doctor Appointment in 3 Easy Steps

Calender Icon

I know my symptoms but I don't know whom to consult

Need Help?

Call US

+91 80788 80788

Address

Livasa Healthcare Group Corporate Office,Phase-8, Industrial Area, Sector 73, Sahibzada Ajit Singh Nagar, Punjab 160071

Email

livasacare@livasahospitals.in